Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for ...

US gene therapy company bluebird bio (Nasdaq: BLUE) announced that after three weeks of engagement, including a timeline ...

Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...

China’s Chime Biologics has formed a strategic partnership with European biosimilars specialist Polpharma Biologics to ...

US biotech Wayfinder Biosciences has entered a research collaboration with Japanese drugmaker Daiichi Sankyo (TSE: 4568) to ...

US biotech Myeloid Therapeutics has restructured its operations to concentrate on two cancer programs already in the clinic, ...

Californian biotech Glycomine has raised $115 million in a Series C financing to advance its lead candidate, GLM101, into a ...

Italian pharma major Recordati (RECI: MI) today announced that the US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Isturisa (osilodrostat) for the ...

French drugmaker Ipsen (Euronext: IPN) today presented sales for the first quarter of 2025. The company did not release any ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

US President Donald Trump has passed an executive order that answers the pharmaceutical industry’s calls for the scrapping of ...

UK pharm major GSK (LSE: GSK) has breached the ABPI Code of Practice for the Industry and brought discredit upon, and ...